A Double Blind Clinical Trial of DCS for Food Anxiety

Completed · Not applicable · Has a placebo group

Conditions studied: Anorexia and Bulimia Nervosa

In brief

This is a pilot study investigating if cycloserine (DCS; a learning enhancement medication) augments exposure therapy for food anxiety in patients with anorexia and bulimia nervosa. The investigators expect that (a) exposure therapy will reduce anxiety (b) anxiety will be reduced more in the DCS relative to placebo condition (c) participants in the DCS condition will have a greater increase in Body Mass Index.

Key facts

Study ID

NCT01996644

Run by

Washington University School of Medicine

People needed

47

Starts

2013-02-01

Expected to finish

2014-02-01

Last updated by the study team

2018-03-27

Who can join

Age: 14 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed with Anorexia Nervosa, Bulimia Nervosa, Eating Disorder Not Otherwise Specified

You may not qualify if…

• Pregnant or planning on becoming pregnant
• Psychotic or Manic

Where it is running

• Washington University — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.